RxDoctor Payments Data

Patrick Casey, MD

Sports Medicine · Concord, NHNPI 1760416234

Payments from drug & device makers

What this record shows

8 manufacturers reported payments, led by Arthrex at 58.8% of the total. Reporting peaked in 2019 at $847 and has fallen 79.5% since, to $174 in 2025.

$1,440in general payments, 2019–2025

Across 22 payments — averaging $65.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$847
  • W. L. Gore & Associates, Inc.$182
  • Miach Orthopaedics, Inc.$150
  • Powerlink AI, Inc.$124
  • Kairos Surgical Inc$46
  • Bioventus LLC$42
  • plus $50 from 2 others

What the payments were for

  • Travel & lodging$63844%
  • Food & beverage$80356%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,440 in reported general payments places this provider in the 55th percentile of 38 sports medicine providers in New Hampshire.

See all sports medicine providers in New Hampshire

Medicare billing

Part B allowed, 2024
$149,951
Medicare patients
475
Services billed
3,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam11$32

Paid to pharmacies, not to this prescriber.

Other sports medicine in Concord

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →